2004- Altis Biologics, in consortium with the Tshwane University of Technology ... The Tshwane University of Technology and Bone SA (organization incorporated not for gain) is awarded a Innovation Fund Grant totalling R14.8 million (2.1 million USD) to develop porcine bone morphogenetic protein complex as a human bone regeneration biomaterial. LINKS http://free.financialmail.co.za/innovations/06/0901/index.html http://free.financialmail.co.za/innovations/06/0901/hinn.htm TT100: http://www.tt100.co.za/categories-and-accolades.html Innovation Fund – NRF: http://www.innovationfund.ac.za/downloads/marketing/if_annual_report_04-05.pdf Market Resrach.com – World Study on Regenerative Medicine http://www.marketresearch.com/map/prod/1467741.html International Journal of Biotech: http://www.utoronto.ca/jcb/about/publications/rm_developing.pdf Certificate of recording of a Pharmacy: downloads/Certificate_of_recording_of_a_Pharmacy_170806.pdf Inspection by SAPC Council: downloads/Inspection_by_SAPC_Council_Y53204_(16082006).pdf Licence number GP00099M: downloads/Licence_number_GP00099M_(16082006).pdf Licence for the Premises: downloads/Licence_for_the_Premises_(16082006).pdf Registration as a Responsible Pharmacist: downloads/Registration_as_a_Responsible_Pharmacist_170806.pdf

Altis Biologics secures... 2003- Altis Biologics secures a management contract for the start-up and running of the Centre for Tissue Engineering (CTE)... read more Altis Biologics awards license... 2004- Altis Biologics awards a license agreement to Osteogenix (Pty) Ltd for Southern Africa for the manufacture... read more